High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 1 of the 5 sources its claims cite were checked for support.
Abstract
A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99 x 10(-16)). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53 x 10(-12)), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80 x 10(-13). Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE-associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
Overview
CoChat Summary
## TL;DR
This study used high-density MHC SNP screening plus HLA-DRB1 genotyping in European-ancestry SLE cases/families to show that multiple, independent susceptibility regions contribute to SLE risk. The strongest signals were at HLA-DRB1, with the top SNP rs3117103 also showing strong association, and follow-up conditional analyses supported additional effects in OR2H2, CREBL1, MICB, and DQB2.
## Key findings
- In 1,610 Caucasian SLE cases and 1,470 parents, the strongest HLA-DRB1 associations were for DRB1*0301 (OR = 2.21, p = 2.53×10−12), DRB1*1401 (OR = 0.50, p = 0.0002), and DRB1*1501 (OR = 1.39, p = 0.0032).
- Among 1,974 MHC SNPs passing quality control, the strongest SNP association was rs3117103 (OR = 2.44, p = 2.80×10−13); the paper also reports rs3117103 remained strong in a more homogeneous Northern European subset (OR = 2.49, p = 1.62×10−13).
- Conditional haplotype and stepwise logistic regression analyses identified independent signals in multiple regions: OR2H2 (rs362521, p = 0.006), CREBL1 (rs8283, p = 0.01), DQB2 (rs7769979, p = 0.003; rs10947345, p = 0.0004), and MICB (rs3828903, p = 0.006).
- The strongest associated extended haplotype contained DRB1*0301 (15% transmitted vs. 6% non-transmitted; OR = 2.63, p = 8.32×10−15); a second associated haplotype contained DRB1*1501 (9% transmitted vs. 6% non-transmitted; OR = 1.54, p = 0.0025).
## Methods
- Family-based and case-based genetic association study of 1,610 Caucasian SLE cases and 1,470 parents from trio families; cases came from three independent collections, and all SLE cases met American College of Rheumatology criteria.
- Genotyping included HLA-DRB1, 2,360 MHC SNPs on Illumina’s Combined MHC panel, and 384 ancestry informative markers; after quality control, 2,873 samples and 1,974 MHC SNPs remained for analysis.
- Main analyses used RPE, univariate association tests, TDT, conditional haplotype methods, stepwise logistic regression, haplotype analysis, LD analysis, and BEAGLE/PHASE/UNPHASED/WHAP/PLINK/STATA/SAS as described in the paper.
## Limitations
- The paper states that MHC coverage was not comprehensive: the marker set was not designed to directly assess rare variants or multi-allelic markers such as indels or copy-number variants, and it did not characterize other classical HLA genes besides HLA-DRB1.
- The authors note they cannot determine which associated variants are causal versus proxies in LD, so the reported associations are not proof of causation.
- Evident from the text: the study analyzed only European-ancestry/Caucasian samples, and the authors explicitly say non-European populations were not examined and should be a focus for future work.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 1 Not checked · 52 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21.”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
What the sources say
- Not checked — no full text of the sourcecites [8] Graham RR Ortmann WA Langefeld CD Jawaheer D Selby SA 2002 Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71 543 553 12145745 PMC379191 source
- Not checked — no full text of the sourcecites [9] Graham RR Ortmann W Rodine P Espe K Langefeld C 2007 Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15 823 830 17406641 source
- Supportedcites [10] Harley JB Alarcon-Riquelme ME Criswell LA Jacob CO Kimberly RP 2008 Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 204 210 18204446 PMC3712260 source
The genome-wide association results report the strongest SLE association in the HLA (MHC) region at chromosome 6p21.3, with two partially independent effects there. This supports a substantial genetic contribution from that region, without identifying the specific causal genes. (LLM, conf=0.90)
plainstates a causen = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004).”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
plainstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions.”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
boostedstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032).”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
plainstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004).”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
boostedstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 54 claims and every source verdict.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 2×
“Transmission disequilibrium testing (TDT) [21] analyses of individual markers were performed using the PLINK program [22].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · cited 2×
“of Rheumatology classification criteria for SLE [35,36].”
BackgroundHochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Browning, S. R., & Browning, B. L. (2007) · The American Journal of Human Genetics · doi:10.1086/521987 · Cited by 3,210 · cited 1×
“Missing genotypes for cases and non-transmitted controls were inferred using default parameters in BEAGLE v2.1.3”
MethodInfluentialEfficiency and power in genetic association studies
de Bakker, P. I. W., Yelensky, R., Pe'er, I., Gabriel, S. B., Daly, M. J., & Altshuler, D. (2005) · Nature Genetics · doi:10.1038/ng1669 · Cited by 1,688
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309 · cited 1×
“More recently, genome wide association scans in SLE also underscore the importance of the MHC [10,11,12].”
BackgroundSelf-citationGene map of the extended human MHC
Horton, R., Wilming, L., Rand, V., Lovering, R. C., Bruford, E. A., Khodiyar, V. K., Lush, M. J., Povey, S., Talbot, C. C., Wright, M. W., et al. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1489 · Cited by 1,198 · cited 1×
“, spanning a total of 7.6 Mb and comprised of five subregions that include the original ‘classical’ MHC”
BackgroundInfluentialPedigree disequilibrium tests for multilocus haplotypes.
Dudbridge, F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10252 · Cited by 1,135 · cited 1×
“Similarly, for the multi-allelic HLA-DRB1 locus, all pairwise measures of LD with MHC region SNPs were determined using UNPHASED (LD option) [42].”
MethodComplete sequence and gene map of a human major histocompatibility complex
The MHC sequencing consortium (1999) · Nature · doi:10.1038/44853 · Cited by 1,065
Cited by
Items 101–131 of 131
Immunogenetic Profiling of SLE and LN among Jordanian Patients
Khdair, S. I., Al-Bdour, R., Jarrar, W., Hammad, A. M., Al-Jayeh, A., Masa’deh, M., Adwan, M. H., & Farah, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12121955 · Cited by 5
“Human leukocyte antigens (HLA), specifically HLA-class II genes, are one of the main candidate genes that increase the susceptibility to SLE [8,9].”
BackgroundHua, L., Sui, W., Tan, Q., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2416 · Cited by 4
“The major histocompatibility complex (MHC) located on chromosome 6p21 is one of the key factors that contribute to the development of SLE (3).”
Vester, S. K., & Vyse, T. J. (2019) · Rare diseases of the immune system · doi:10.1007/978-3-030-03934-9_1 · Cited by 4
Introductory Chapter: Systemic Lupus Erythematosus - Different Predisposing Factors
Khan, W. A. (2017) · Lupus · doi:10.5772/intechopen.69277 · Cited by 3
Xie, Q., Lou, Q., Huang, S., Hu, H.-Q., Li, S., Zhang, M., Sun, X., Xu, J., Jiang, S., Liu, S., et al. (2019) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000986 · Cited by 3
“As is true for SLE, a well-known contributor to the disease risk is the major histocompatibility complex gene (s) on chromosome 6p21, which contains a large number of autoimmune disease-associated genes.(15,16) In humans, HspA1A, HspA1B, and HspA1L are the 3 members of Hsp70 gene family within the major histocompatibi…”
BackgroundLin, W., Chen, H., Yang, C., et al. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102379 · Cited by 3
Lee, J. S., Bae, J. S., Kim, J., Kim, Y., Park, T. J., Pasaje, C. F. A., Park, B., Cheong, H. S., Uh, S., Park, J., et al. (2012) · Respiratory Care · doi:10.4187/respcare.01480 · Cited by 3
Ketkar, S., Dai, H., Burrage, L. C., Murdock, D. R., Dawson, B., Acosta‐Herrera, M., Kerick, M., Martín, J. E.-S., Wilhelm, K. O., Asmussen, J. K., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.05.009 · Cited by 6
Spagnolo, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54429-0.00004-5 · Cited by 2
HLA-DRB1 and HLA-DQB1 genes in patients diagnosed with systemic lupus erythematosus in Guatemala
Barrios-Menéndez, J. C., Alvarado, C. C. C., Cayax, L. I., López, F., Santizo, A., Herrera, M. A., Hernández-Zaragoza, D. I., & Escobar-Castro, K. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.110803 · Cited by 1
Nagy, S. S., & Kesselman, M. M. (2024) · Cureus · doi:10.7759/cureus.76130 · Cited by 2
Wu, Y., Fengjiao, W., Xiao, L., Chen, Y., & Li, L. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168274 · Cited by 2
HLA Disease Associations: Detecting Primary and Secondary Disease Predisposing Genes
Thomson, G. J., Mack, S. J., Valdes, A. M., Barcellos, L. F., Hollenbach, J. A., Helmberg, W. M. C., Single, R. M., & Luther, M. (2011) · Cited by 1
Self-citationHigh soluble HLA‐DQB2 levels in posttransplant serum are associated with kidney graft dysfunction
Mine, K. L., de Marco, R., Raimundo, T. R. F., Ernesto, J. V., Pestana, J. O. M., Junior, H. T. S., & Gerbase‐DeLima, M. (2022) · International Journal of Immunogenetics · doi:10.1111/iji.12569 · Cited by 1
Genetic Susceptibility to Autoimmune Disorders
Lauwerys, B. R. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022406 · Cited by 1
Retinal and Choroidal Manifestations of Systemic Lupus Erythematosus (SLE)
Arévalo, J. F., Arévalo, J. F., Lowder, C. Y., et al. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3646-1_18
Genomic Profiling Reveals the Potential Role of TCL1A and MDR1 Deficiency in Chemotherapy-Induced
Tziros, C., Lewis, J. F., Katz, R. J., et al. (2013)
Creation of a Retroviral RNAi Knockdown System to Investigate Gene Variants in SLE
Lifeso, K. (2013) · TSpace (University of Toronto)
Avaliação da saúde reprodutiva de mulheres com lúpus eritematoso sistêmico
Pereira, K. D. (2013) · doi:10.47749/t/unicamp.2013.917244 · Cited by 1
Confirmation and expression analysis of three predicted genes in sheep MHC region
Sha-Sha, J. I. A. O., Ka, L., Li, G., et al. (2011) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2011.01353
“[9] Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J, Noble JA, Taylor KE, Quach DL, Chung SA, Kelly JA, Moser KL, Behrens TW, Seldin MF, Thomson G, Harley JB, Gaffney PM, Criswell LA.”
BackgroundGianfrancesco, M. A. (2016) · eScholarship (California Digital Library) · Cited by 1
Fetal-Maternal HLA Relationships and Autoimmune Disease
Cruz, G. (2016) · eScholarship (California Digital Library)
Implications of Endogenous Retroelements in the Etiopathogenesis of Systemic Lupus Erythematosus
Ukadike, K. C., & Mustelin, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040856 · Cited by 23
“The most significant associations are found in the major histocompatibility complex II (MHC II), which include alleles of HLA-DR2, HLA-DR3, and HLA-DQ2 [8–10].”
BackgroundReed, A., & CHOWDHARY, V. R. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.3550957.3253056
Kopp, J. B. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.9802957.10503055
(2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833755c4
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-26011-4.09952-6
Hart, A. P., Kotzin, J. J., Schulz, S., Dunham, J., Keenan, A. L., Baker, J. F., Wells, A. D., Beiting, D. P., & Laufer, T. M. (2024) · JCI Insight · doi:10.1172/jci.insight.176811 · Cited by 3
Causal associations between Sjögren’s syndrome and subtypes of endometrial cancer
Zhu, Y., Wu, Q., Hu, L., et al. (2026) · BMC Immunology · doi:10.1186/s12865-026-00821-z
Obadic, B. G., Katsukunya, J. N., Davidson, B., Jones, E. S. W., Hodkinson, B., Freercks, R., Dandara, C., & Mnika, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167383
“Several studies have consistently replicated these associations, particularly in European populations, showing that carriers of these haplotypes have around a two-fold increased risk of SLE [37,39,42,44].”
Metadata
- Authors
- Barcellos, L. F., May, S. L., Ramsay, P. P., Quach, H. L., Lane, J. A., Nititham, J., Noble, J. A., Taylor, K. E., Quach, D. L., Chung, S. A., Kelly, J. A., Moser, K. L., Behrens, T. W., Seldin, M. F., Thomson, G., Harley, J. B., Gaffney, P. M., & Criswell, L. A.
- Affiliations
- University of California, Berkeley (US)
- UCSF Benioff Children's Hospital (US)
- University of California, San Francisco (US)
- Oklahoma Medical Research Foundation (US)
- Genentech (US)
- University of California, Davis (US)
- Corresponding author
- Criswell, Lindsey A.
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-10-23
- Volume
- 5
- Issue
- 10
- Pages
- e1000696
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC2758598
- OpenAlex
- W2010016129
- Semantic Scholar
- e76a1b3dcde88cab4e7473278eacb92ff1cc994e
- Cited by
- 131
- References
- 50
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 8 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 13 · 2012: 19
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Veterans Affairs
- Lupus Research Alliance
- National Institutes of Health (n01ar62277-9-0-1, n01ai40076-11-0-2, 5m01rr000079-42, AI063274, AI24717, AI40076, AI62629)
- University of California, San Francisco
- National Institute of Allergy and Infectious Diseases (AI62629, AI-31584, AI-24717, R01AI063274, R37AI024717, R01AI031584, AI53747, AI-063274, R21AI053747, R56AI063274, U19AI062629, N01 AI040076, R01AI024717)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052125, AR19084, R01AR042460, R01AR043274, AR-052300, AR043274, AR02175, R01AR052300, P30AR053483, AR 42460, N01-AR062277, AR22804, AR052125, K24AR002175, P50AR048940, AR 48940)
- National Institute of Dental and Craniofacial Research (DE15223, R01DE015223)
- National Center for Research Resources (RR20143, P20RR020143, M01-RR000079)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- systemic lupus erythematosus, major histocompatibility complex, HLA-DRB1, HLA-DRB1*0301, HLA-DRB1*1501, MICB, ancestry informative markers, haplotype association, risk genes
- MeSH terms
- Adult, Female, HLA-DR Antigens, Humans, Lupus Erythematosus, Systemic, Major Histocompatibility Complex, Male, Middle Aged, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Young Adult, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.